SeekingAlpha · Aug 7, 2026
The Joint Corp. (JYNT) Q2 2026 Earnings Call Transcript
The Joint Corp. (JYNT) Q2 2026 Earnings Call August 6, 2026 5:00 PM EDTCompany ParticipantsSanjiv Razdan - CEO, President & DirectorScott Bowman - Chief...
NASDAQ · JYNT
Healthcare · Medical - Care Facilities
$8.63
Down-$0.16 (-1.86%)
Updated Sep 17, 2026, 7:41 PM
SID Score
3.7/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 20 trading sessions · Daily adjusted prices
JYNT closed at $8.63 after 20 trading sessions, up 4.86% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 16, 2026 | $8.47 | $8.67 | $8.39 | $8.63 | 107.06K |
| Sep 15, 2026 | $8.33 | $8.575 | $8.23 | $8.47 | 118.75K |
| Sep 14, 2026 | $7.85 | $8.31 | $7.82 | $8.30 | 107.92K |
| Sep 11, 2026 | $8.11 | $8.11 | $7.81 | $7.85 | 96.96K |
| Sep 10, 2026 | $8.08 | $8.11 | $7.99 | $8.03 | 69.86K |
| Sep 9, 2026 | $8.13 | $8.155 | $8.03 | $8.09 | 91.68K |
| Sep 8, 2026 | $8.26 | $8.30 | $8.13 | $8.19 | 139.48K |
| Sep 4, 2026 | $8.24 | $8.37 | $8.19 | $8.32 | 52.91K |
| Sep 3, 2026 | $8.30 | $8.325 | $8.15 | $8.28 | 70.67K |
| Sep 2, 2026 | $8.35 | $8.42 | $8.24 | $8.24 | 100.63K |
| Sep 1, 2026 | $8.415 | $8.50 | $8.295 | $8.36 | 68.49K |
| Aug 31, 2026 | $8.38 | $8.53 | $8.32 | $8.44 | 76.75K |
| Aug 28, 2026 | $8.46 | $8.56 | $8.35 | $8.43 | 42.4K |
| Aug 27, 2026 | $8.50 | $8.58 | $8.33 | $8.41 | 69.04K |
| Aug 26, 2026 | $8.65 | $8.65 | $8.45 | $8.54 | 45.01K |
| Aug 25, 2026 | $8.51 | $8.615 | $8.435 | $8.45 | 35.19K |
| Aug 24, 2026 | $8.39 | $8.52 | $8.32 | $8.44 | 65.84K |
| Aug 21, 2026 | $8.28 | $8.48 | $8.28 | $8.44 | 46.6K |
| Aug 20, 2026 | $8.25 | $8.40 | $8.23 | $8.25 | 74.12K |
| Aug 19, 2026 | $8.53 | $8.53 | $8.11 | $8.23 | 83.77K |
The latest Smart Investors Daily articles mentioning JYNT.
JYNT research
Company profile and research snapshot.
The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The Company has one operating business segment; The Franchise Operations segment which is comprised of the operating activities of the franchise business unit. The Franchise Operations segment derives revenue from customers by providing access to the Company's franchise license, which represents symbolic intellectual property.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 8, 2025 | B. Riley Securities | Buy | — |
| May 9, 2025 | Lake Street | Buy | — |
| Nov 8, 2024 | Roth MKM | Buy | — |
| May 6, 2024 | B. Riley Securities | Buy | — |
| May 3, 2024 | Roth MKM | Buy | — |
No generated briefing is available yet.
SeekingAlpha · Aug 7, 2026
The Joint Corp. (JYNT) Q2 2026 Earnings Call August 6, 2026 5:00 PM EDTCompany ParticipantsSanjiv Razdan - CEO, President & DirectorScott Bowman - Chief...
SeekingAlpha · Aug 6, 2026
2026-08-06. The following slide deck was published by The Joint Corp.
Benzinga · Aug 6, 2026
Joint (NASDAQ:JYNT) reported quarterly earnings of $0.05 per share which missed the analyst consensus estimate of $0.11 by 54.55 percent. This is a 400 percent increase over earnings of $0.01 per share from the same
Yahoo · Jul 1, 2026
The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic® network, today announced its official entry into Rhode Island, marking the brand's expansion to its 44th state with the grand opening of a new clinic in Warwick.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning JYNT.